JNP
Morgan Stanley’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-7,649
| Closed | -$66K | – | 6966 |
|
|
2018
Q2 | $66K | Sell |
7,649
-49,925
| -87% | -$431K | ﹤0.01% | 5848 |
|
|
2018
Q1 | $584K | Buy |
57,574
+4,616
| +9% | +$46.8K | ﹤0.01% | 4911 |
|
|
2017
Q4 | $256K | Sell |
52,958
-198
| -0.4% | -$957 | ﹤0.01% | 5323 |
|
|
2017
Q3 | $242K | Sell |
53,156
-23,945
| -31% | -$109K | ﹤0.01% | 5255 |
|
|
2017
Q2 | $390K | Buy |
77,101
+1,524
| +2% | +$7.71K | ﹤0.01% | 4961 |
|
|
2017
Q1 | $359K | Buy |
75,577
+17,774
| +31% | +$84.4K | ﹤0.01% | 5030 |
|
|
2016
Q4 | $324K | Sell |
57,803
-6,674
| -10% | -$37.4K | ﹤0.01% | 5151 |
|
|
2016
Q3 | $358K | Sell |
64,477
-1,090
| -2% | -$6.05K | ﹤0.01% | 4725 |
|
|
2016
Q2 | $459K | Sell |
65,567
-28,790
| -31% | -$202K | ﹤0.01% | 4479 |
|
|
2016
Q1 | $623K | Sell |
94,357
-117,056
| -55% | -$773K | ﹤0.01% | 4283 |
|
|
2015
Q4 | $2.18M | Sell |
211,413
-115,776
| -35% | -$1.19M | ﹤0.01% | 3417 |
|
|
2015
Q3 | $3.85M | Buy |
327,189
+250,958
| +329% | +$2.96M | ﹤0.01% | 2887 |
|
|
2015
Q2 | $698K | Sell |
76,231
-6,074
| -7% | -$55.6K | ﹤0.01% | 4472 |
|
|
2015
Q1 | $511K | Sell |
82,305
-5,987
| -7% | -$37.2K | ﹤0.01% | 4640 |
|
|
2014
Q4 | $494K | Sell |
88,292
-1,800
| -2% | -$10.1K | ﹤0.01% | 4671 |
|
|
2014
Q3 | $530K | Sell |
90,092
-2,214
| -2% | -$13K | ﹤0.01% | 4529 |
|
|
2014
Q2 | $633K | Sell |
92,306
-36
| -0% | -$247 | ﹤0.01% | 4411 |
|
|
2014
Q1 | $666K | Buy |
92,342
+2,507
| +3% | +$18.1K | ﹤0.01% | 4346 |
|
|
2013
Q4 | $594K | Buy |
89,835
+33,676
| +60% | +$223K | ﹤0.01% | 4319 |
|
|
2013
Q3 | $408K | Buy |
+56,159
| New | +$408K | ﹤0.01% | 4468 |
|